LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients

Gynecologic Oncology

Volumn 132, Issue 2, 2014, Pages 462-467

  Akers, Stacey N ^a   Moysich, Kirsten ^a   Zhang, Wa ^a,b   Collamat Lai, Golda ^a   Miller, Austin ^a   Lele, Shashikant ^a   Odunsi, Kunle ^a   Karpf, Adam R ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Alu; DNA methylation; Epithelial ovarian cancer; LINE1; Repetitive elements

Indexed keywords

ALU; DNA METHYLATION; EPITHELIAL OVARIAN CANCER; LINE1; REPETITIVE ELEMENTS;

ADULT; AGED; AGED, 80 AND OVER; ALU ELEMENTS; DNA METHYLATION; FEMALE; HUMANS; LEUKOCYTES; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RISK ASSESSMENT;

EID: 84894054247     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.12.024     Document Type: Article

References (41)

1. Cancer facts and figures 2013 2013 American Cancer Society
2. T. Sudo Molecular-targeted therapies for ovarian cancer: prospects for the future Int J Clin Oncol 17 2012 424 429
3. S. Gopalakrishnan, B.O. Van Emburgh, and K.D. Robertson DNA methylation in development and human disease Mutat Res 647 2008 30 38
4. S.B. Baylin, and P.A. Jones A decade of exploring the cancer epigenome - biological and translational implications Nat Rev Cancer 11 2011 726 734
5. M. Ehrlich DNA methylation in cancer: too much, but also too little Oncogene 21 2002 5400 5413
6. A. Eden, F. Gaudet, A. Waghmare, and R. Jaenisch Chromosomal instability and tumors promoted by DNA hypomethylation Science 300 2003 455
7. A.R. Karpf, and S. Matsui Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells Cancer Res 65 2005 8635 8639
8. C. Marsit, and B. Christensen Blood-derived DNA methylation markers of cancer risk Adv Exp Med Biol 754 2013 233 252
9. J.Y. Choi, S.R. James, P.A. Link, S.E. McCann, C.C. Hong, and W. Davis et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer Carcinogenesis 30 2009 1889 1897
10. D.T. Hsiung, C.J. Marsit, E.A. Houseman, K. Eddy, C.S. Furniss, and M.D. McClean et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma Cancer Epidemiol Biomarkers Prev 16 2007 108 114
11. U. Lim, A. Flood, S.W. Choi, D. Albanes, A.J. Cross, and A. Schatzkin et al. Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women Gastroenterology 134 2008 47 55
12. L.E. Moore, R.M. Pfeiffer, C. Poscablo, F.X. Real, M. Kogevinas, and D. Silverman et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study Lancet Oncol 9 2008 359 366
13. M. Pufulete, R. Al-Ghnaniem, A.J. Leather, P. Appleby, S. Gout, and C. Terry et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study Gastroenterology 124 2003 1240 1248
14. H.C. Wu, L. Delgado-Cruzata, J.D. Flom, M. Kappil, J.S. Ferris, and Y. Liao et al. Global methylation profiles in DNA from different blood cell types Epigenetics 6 2011 76 85
15. K. Brennan, and J.M. Flanagan Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res (Phila) 5 2012 1345 1357
16. H.D. Woo, and J. Kim Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis PLoS One 7 2012 e34615
17. A.R. Karpf Genome-wide hypomethylation and cancer risk - letter Cancer Prev Res (Phila) 6 2013 753
18. T.G. Fanning, and M.F. Singer LINE-1: a mammalian transposable element Biochim Biophys Acta 910 1987 203 212
19. O.K. Pickeral, W. Makalowski, M.S. Boguski, and J.D. Boeke Frequent human genomic DNA transduction driven by LINE-1 retrotransposition Genome Res 10 2000 411 415
20. B. Jurgens, B.J. Schmitz-Drager, and W.A. Schulz Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma Cancer Res 56 1996 5698 5703
21. H.H. Kazazian Jr., and J.V. Moran The impact of L1 retrotransposons on the human genome Nat Genet 19 1998 19 24
22. C.M. Suter, D.I. Martin, and R.L. Ward Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue Int J Colorectal Dis 19 2004 95 101
23. D. Takai, Y. Yagi, N. Habib, T. Sugimura, and T. Ushijima Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis Jpn J Clin Oncol 30 2000 306 309
24. K. Chalitchagorn, S. Shuangshoti, N. Hourpai, N. Kongruttanachok, P. Tangkijvanich, and D. Thong-ngam et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis Oncogene 23 2004 8841 8846
25. A.R. Florl, R. Lower, B.J. Schmitz-Drager, and W.A. Schulz DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas Br J Cancer 80 1999 1312 1321
26. E.M. Wolff, H.M. Byun, H.F. Han, S. Sharma, P.W. Nichols, and K.D. Siegmund et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer PLoS Genet 6 2010 e1000917
27. K. Hur, P. Cejas, J. Feliu, J. Moreno-Rubio, E. Burgos, and C.R. Boland et al. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis Gut 2013 (in press)
28. M.A. Batzer, and P.L. Deininger Alu repeats and human genomic diversity Nat Rev Genet 3 2002 370 379
29. A.M. Karst, and R. Drapkin Ovarian cancer pathogenesis: a model in evolution J Oncol 2010 2010 932371
30. L. Dubeau The cell of origin of ovarian epithelial tumours Lancet Oncol 9 2008 1191 1197
31. M.L. Kurta, K.B. Moysich, J.L. Weissfeld, A.O. Youk, C.H. Bunker, and R.P. Edwards et al. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study Cancer Epidemiol Biomarkers Prev 21 2012 1282 1292
32. A. Woloszynska-Read, P. Mhawech-Fauceglia, J. Yu, K. Odunsi, and A.R. Karpf Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer Clin Cancer Res 14 2008 3283 3290
33. V. Bollati, S. Fabris, V. Pegoraro, D. Ronchetti, L. Mosca, and G.L. Deliliers et al. Differential repetitive DNA methylation in multiple myeloma molecular subgroups Carcinogenesis 30 2009 1330 1335
34. A.S. Yang, M.R. Estecio, K. Doshi, Y. Kondo, E.H. Tajara, and J.P. Issa A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements Nucleic Acids Res 32 2004 e38
35. M. Widschwendter, G. Jiang, C. Woods, H.M. Muller, H. Fiegl, and G. Goebel et al. DNA hypomethylation and ovarian cancer biology Cancer Res 64 2004 4472 4480
36. A. Woloszynska-Read, W. Zhang, J. Yu, P.A. Link, P. Mhawech-Fauceglia, and G. Collamat et al. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage Clin Cancer Res 17 2011 2170 2180
37. A.E. Teschendorff, U. Menon, A. Gentry-Maharaj, S.J. Ramus, S.A. Gayther, and S. Apostolidou et al. An epigenetic signature in peripheral blood predicts active ovarian cancer PLoS One 4 2009 e8274
38. R.P. Nagarajan, S.D. Fouse, R.J. Bell, and J.F. Costello Methods for cancer epigenome analysis Adv Exp Med Biol 754 2013 313 338
39. F. Fang, C. Balch, J. Schilder, T. Breen, S. Zhang, and C. Shen et al. A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer Cancer 116 2010 4043 4053
40. D. Matei, F. Fang, C. Shen, J. Schilder, A. Arnold, and Y. Zeng et al. Epigenetic resensitization to platinum in ovarian cancer Cancer Res 72 2012 2197 2205
41. K. Odunsi, J. Matsuzaki, S.R. James, P. Mhawech-Fauceglia, T. Tsuji, and A. Miller et al. Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer Cancer Immunol Res 2 2014 37 49